| Document and Entity Information | Aug. 04, 2020 |
| Cover [Abstract] | |
| Document Type | 8-K/A |
| Document Period End Date | Aug. 4, 2020 |
| Entity Registrant Name | HAEMONETICS CORPORATION |
| Entity Central Index Key | 0000313143 |
| Amendment Flag | true |
| Entity Incorporation, State or Country Code | MA |
| Entity File Number | 001-14041 |
| Entity Tax Identification Number | 04-2882273 |
| Entity Address, Address Line One | 125 Summer Street |
| Entity Address, City or Town | Boston |
| Entity Address, State or Province | MA |
| Entity Address, Postal Zip Code | 02110 |
| City Area Code | 781 |
| Local Phone Number | 848-7100 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common stock, $.01 par value per share |
| Trading Symbol | HAE |
| Security Exchange Name | NYSE |
| Entity Emerging Growth Company | false |
| Amendment Description | On August 4, 2020, Haemonetics Corporation issued a press release announcing its financial results for the first quarter ended June 27, 2020. A copy of the press release was furnished under Items 2.02 and 9.01 on a Current Report on Form 8-K filed on August 4, 2020 (the “Report”), however, the Report was only identified or “tagged” in the Edgar filing as a Current Report on Form 8-K with disclosure under Item 9.01. This Amendment No. 1 to the Current Report on Form 8-K/A is being filed solely to identify or “tag” both Items 2.02 and 9.01 on the Edgar filing of the Report. No other changes are made with this filing. |
